Stress cardiomyopathy laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Dima Nimri (talk | contribs) |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
=== | Laboratory findings in patients with stress cardiomyopathy include:<ref name="pmid19106400">{{cite journal |vauthors=Akashi YJ, Goldstein DS, Barbaro G, Ueyama T |title=Takotsubo cardiomyopathy: a new form of acute, reversible heart failure |journal=Circulation |volume=118 |issue=25 |pages=2754–62 |year=2008 |pmid=19106400 |pmc=4893309 |doi=10.1161/CIRCULATIONAHA.108.767012 |url=}}</ref> | ||
*Elevated levels of [[BNP]] | |||
*Elevated levels of [[serum]] [[catecholamines]] | |||
*Elevated levels of [[cardiac enzymes]] | |||
==References== | ==References== | ||
Revision as of 18:51, 6 January 2017
|
Stress cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Unstable angina/non ST elevation myocardial infarction in Stress (Takotsubo) Cardiomyopathy |
|
Case Studies |
|
Stress cardiomyopathy laboratory findings On the Web |
|
American Roentgen Ray Society Images of Stress cardiomyopathy laboratory findings |
|
Risk calculators and risk factors for Stress cardiomyopathy laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Laboratory Findings
Laboratory findings in patients with stress cardiomyopathy include:[1]
- Elevated levels of BNP
- Elevated levels of serum catecholamines
- Elevated levels of cardiac enzymes
References
- ↑ Akashi YJ, Goldstein DS, Barbaro G, Ueyama T (2008). "Takotsubo cardiomyopathy: a new form of acute, reversible heart failure". Circulation. 118 (25): 2754–62. doi:10.1161/CIRCULATIONAHA.108.767012. PMC 4893309. PMID 19106400.